Clinical trial
Can Loco-regional Anesthesia With Liposomal Bupivacaine Reduce Intra- and Post-operative Narcotic Use in Patients Undergoing Lower Extremity Revascularization? A Prospective, Triple Blinded, Randomized Trial.
NCT05992896 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Can Loco-regional Anesthesia With Liposomal Bupivacaine Reduce Intra- and Post-operative Narcotic Use in Patients Undergoing Lower Extremity Revascularization? A Prospective, Triple Blinded, Randomized Trial.
- Lead sponsor
- Mayo Clinic
- Phase
- Phase 4
- Overall status
- Terminated
- Start date
- September 26, 2023
- Completion date
- June 30, 2025
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.